The efficacy of coaxial percutaneous iodine-125 seed implantation combined with arterial infusion chemotherapy for advanced pancreatic cancer: a randomized clinical trial

References

• Commission GOoNH. 2022. Standard for diagnosis and treatment of pancreatic cancer (2022 edition). J Clin Hepatol. 38(5):10. doi: 10.3969/j.issn.1001-5256.2022.05.007
   Google Scholar
• Dahan L, Williet N, Le Malicot K, Phelip JM, Desrame J, Bouché O, Petorin C, Malka D, Rebischung C, Aparicio T, et al. 2021. Randomized phase II trial evaluating two sequential treatments in first line of metastatic pancreatic cancer: results of the PANOPTIMOX-PRODIGE 35 trial. J Clin Oncol. 39(29):3242–3250. doi: 10.1200/JCO.20.03329
   PubMed Web of Science ®Google Scholar
• Hu ZI, O’Reilly EM. 2024. Therapeutic developments in pancreatic cancer. Nat Rev Gastroenterol Hepatol. 21(1):7–24. doi: 10.1038/s41575-023-00840-w
   PubMed Web of Science ®Google Scholar
• Jin TQ, Dai CL, Xu F. 2022. Clinical effect of simultaneous surgical resection of hepatic and pancreatic lesions versus systemic chemotherapy in treatment of resectable pancreatic cancer with liver metastasis. J Clin Hepatol. 38(3):7. doi: 10.3969/j.issn.1001-5256.2022.03.023
   Google Scholar
• Jing F, Hongxiang Y. 2018. Staged nursing care of percutaneous transhepatic biliary drainage combined with 125I seed sequential implantation in the treatment of advanced pancreatic head cancer. Nurs Rehabil J. 17(5):43–46. doi: 10.3969/j.issn.1671-9875.2018.05.015
   Google Scholar
• Kruger S, Schirle K, Haas M, Crispin A, Schirra J, Mayerle J, D'Haese JG, Kunz WG, Ricke J, Ormanns S, et al. 2020. Prolonged time to treatment initiation in advanced pancreatic cancer patients has no major effect on treatment outcome: a retrospective cohort study controlled for lead time bias and waiting time paradox. J Cancer Res Clin Oncol. 146(2):391–399. doi: 10.1007/s00432-019-03061-4
   PubMed Web of Science ®Google Scholar
• Kunzmann V, Siveke JT, Algül H, Goekkurt E, Siegler G, Martens U, Waldschmidt D, Pelzer U, Fuchs M, Kullmann F, et al. 2021. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial. Lancet Gastroenterol Hepatol. 6(2):128–138. doi: 10.1016/S2468-1253(20)30330-7.
   PubMed Web of Science ®Google Scholar
• Lawrence TS, Eisbruch A, Shewach DS. 1997. Gemcitabine-mediated radiosensitization. Semin Oncol. 24(7):S7-24–s27-28. https://pubmed.ncbi.nlm.nih.gov/9194476/
   Google Scholar
• Li D, Jia YM, Cao PK, Wang W, Liu B, Li YL. 2018. Combined effect of (125)I and gemcitabine on PANC-1 cells: cellular apoptosis and cell cycle arrest. J Cancer Res Ther. 14(7):1476–1481. doi: 10.4103/jcrt.JCRT_43_18
   PubMed Web of Science ®Google Scholar
• Li JK, Lei YY, Tian NZ, Wang XL. 2022. Application advance of transcatheter interventional treatments in advanced pancreatic cancer. Chin J Clin Med. 29(4):7. doi: 10.12025/j.issn.1008-6358.2022.20210239
   Google Scholar
• Liu X, Yang X, Zhou G, Chen Y, Li C, Wang X. 2016. Gemcitabine-based regional intra-arterial infusion chemotherapy in patients with advanced pancreatic adenocarcinoma. Medicine (Baltimore). 95(11):e3098. doi: 10.1097/MD.0000000000003098
   PubMed Web of Science ®Google Scholar
• Liu Y, Ran LH, Huang XQ. 2021. Clinical value of CT-guided implantation of 125I padioactive particles in the treatment of pancreatic cancer. Chin J CT MRI. 19(2):3. doi: 10.3969/j.issn.1672-5131.2021.02.034
   Google Scholar
• Meng H, Nel AE. 2018. Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer. Adv Drug Deliv Rev. 130:50–57. doi: 10.1016/j.addr.2018.06.014
   PubMed Web of Science ®Google Scholar
• Mukherji R, Debnath D, Hartley ML, Noel MS. 2022. The role of immunotherapy in pancreatic cancer. Curr Oncol. 29(10):6864–6892. doi: 10.3390/curroncol29100541
   PubMed Web of Science ®Google Scholar
• Rudra S, Jiang N, Rosenberg SA, Olsen JR, Roach MC, Wan L, Portelance L, Mellon EA, Bruynzeel A, Lagerwaard F, et al. 2019. Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer. Cancer Med. 8(5):2123–2132. doi: 10.1002/cam4.2100
   PubMed Web of Science ®Google Scholar
• Suker M, Nuyttens JJ, Eskens F, Haberkorn BCM, Coene PLO, van der Harst E, Bonsing BA, Vahrmeijer AL, Mieog JSD, Jan Swijnenburg R, et al. 2019. Efficacy and feasibility of stereotactic radiotherapy after folfirinox in patients with locally advanced pancreatic cancer (LAPC-1 trial). EClinicalMedicine. 17:100200. doi: 10.1016/j.eclinm.2019.10.013
   PubMedGoogle Scholar
• Sun D, Cao M, Li H, He S, Chen W. 2020. Cancer burden and trends in China: a review and comparison with Japan and South Korea. Chin J Cancer Res. 32(2):129–139. doi: 10.21147/j.issn.1000-9604.2020.02.01
   PubMed Web of Science ®Google Scholar
• Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, et al. 2013. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 369(18):1691–1703. doi: 10.1056/NEJMoa1304369
   PubMed Web of Science ®Google Scholar
• Wang ZM, Lu J, Zhang LY, Lin XZ, Chen KM, Chen ZJ, Liu FJ, Yan FH, Teng GJ, Mao AW. 2015. Biological effects of low-dose-rate irradiation of pancreatic carcinoma cells in vitro using 125I seeds. World J Gastroenterol. 21(8):2336–2342. doi: 10.3748/wjg.v21.i8.2336
   PubMed Web of Science ®Google Scholar
• Xing L, Lv L, Ren J, Yu H, Zhao X, Kong X, Xiang H, Tao X, Dong D. 2023. Advances in targeted therapy for pancreatic cancer. Biomed Pharmacother. 168:115717. doi: 10.1016/j.biopha.2023.115717
   PubMedGoogle Scholar
• Yang W, Huang H. 2021. Research progress on pain mechanism of pancreatic cancer. J Chongqin Med Univ. 46(9):4. doi: 10.13406/j.cnki.cyxb.002784
   Google Scholar
• Yao HX, Chen GS, Xu L, Qun Z. 2014. CT guide coaxial 125I seeds implantation for the treatment of retroperitoneal lymph node metastasis: analysis of 21 cases. J Intervent Radiol. (01):42–45. http://www.cjir.cn/oa/DArticle.aspx?type=view&id=201307053
   PubMedGoogle Scholar
• Yao HX, ZhuGe Y, Chen ZG, Chen S, Shixiang J, Henyiting Z, Dong Z, Shengqian X. 2022. Effectiveness of CT-guided coaxial method of radioactive 125I seed implantation in the treatment of moderately advanced pancreatic cancer. Zhejiang Med J. 044(010):5. doi: 10.12056/j.issn.1006-2785.2022.44.10.2021-2564
   Google Scholar
• Zhang F, Li D, Ding X, Yang H. 2021. 125I implantation under CT guidance for advanced pancreatic cancer. Chin J Endocr Surg. 15(6):4. doi: 10.3760/cma.j.cn.115807-20200809-00238
   Google Scholar